SEC Form 4 · accession 0000899243-17-024180
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
Oct 11, 2017
Accepted (ET)
Oct 13, 2017 · 8:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 11, 2017 | M | 1,200 | $11.09 | A | 688,346 | D | |
| Common StockF3,F1 | Oct 11, 2017 | S | 1,200 | $63.01 | D | 687,146 | D | |
| Common StockF1 | Oct 11, 2017 | M | 6,699 | $11.09 | A | 693,845 | D | |
| Common StockF4,F1 | Oct 11, 2017 | S | 6,699 | $62.08 | D | 687,146 | D | |
| Common StockF1 | Oct 11, 2017 | M | 6,899 | $11.09 | A | 694,045 | D | |
| Common StockF5,F1 | Oct 11, 2017 | S | 6,899 | $61.33 | D | 687,146 | D | |
| Common StockF1 | Oct 11, 2017 | M | 1,400 | $11.09 | A | 688,546 | D | |
| Common StockF6,F1 | Oct 11, 2017 | S | 1,400 | $60.37 | D | 687,146 | D | |
| Common StockF1 | Oct 11, 2017 | M | 837 | $11.09 | A | 687,983 | D | |
| Common StockF7,F1 | Oct 11, 2017 | S | 837 | $58.86 | D | 687,146 | D | |
| Common StockF1 | Oct 11, 2017 | M | 1,797 | $11.09 | A | 688,943 | D | |
| Common StockF8,F1 | Oct 11, 2017 | S | 1,797 | $57.79 | D | 687,146 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F9 | $11.09 | Oct 11, 2017 | M | 1,200 | D | — | Aug 27, 2018 | Common Stock | 1,200 | 205,951 | D |
| Non-Qualified Stock Option (right to buy)F9 | $11.09 | Oct 11, 2017 | M | 6,699 | D | — | Aug 27, 2018 | Common Stock | 6,699 | 199,252 | D |
| Non-Qualified Stock Option (right to buy)F9 | $11.09 | Oct 11, 2017 | M | 6,899 | D | — | Aug 27, 2018 | Common Stock | 6,899 | 192,353 | D |
| Non-Qualified Stock Option (right to buy)F9 | $11.09 | Oct 11, 2017 | M | 1,400 | D | — | Aug 27, 2018 | Common Stock | 1,400 | 190,953 | D |
| Non-Qualified Stock Option (right to buy)F9 | $11.09 | Oct 11, 2017 | M | 837 | D | — | Aug 27, 2018 | Common Stock | 837 | 190,116 | D |
| Non-Qualified Stock Option (right to buy)F9 | $11.09 | Oct 11, 2017 | M | 1,797 | D | — | Aug 27, 2018 | Common Stock | 1,797 | 188,319 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $62.76 to $63.20. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $61.72 to $62.70. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F5Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $60.70 to $61.68. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F6Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $59.65 to $60.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F7Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $58.60 to $59.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F8Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $57.50 to $58.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F9Shares vested at a rate of 25% on 8/27/09 and monthly thereafter until all the shares were fully vested on 8/27/12.